Skip to main content

Table 2 TNM stage of patients with non-metastatic prostate cancer or metastatic prostate cancer

From: Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

Variables

nmPCa (n = 10)

mPCa (n = 5)

n (%)

Ta

 Tx

 

1 (20)

 T1

  

 T2

5 (50)

 

 T3

5 (50)

2 (40)

 T4

 

2 (40)

N

 Nx

 

1 (20)

 N0

9 (90)

1 (20)

 N1

1 (10)

3 (60)

M

 M0

10 (100)

 

 M1

 

5 (100)

AJCC group (I–IV)b

 I

  

 IIA

  

 IIB

  

 IIC

3 (30)

 

 IIIA

  

 IIIB

4 (40)

 

 IIIC

2 (20)

 

 IVA

1 (10)

 

 IVB

 

5 (100)

  1. nmPCa non-metastatic prostate cancer, mPCa metastatic prostate cancer
  2. aIncluding clinical and pathological T
  3. b2017 AJCC (American Joint Committee on Cancer) Eighth Edition
Back to article page

Microbiome

ISSN: 2049-2618

Contact us